PMID

Data

Article Title

Organization

Design and synthesis of calindol derivatives as potent and selective calcium sensing receptor agonists.

Cnrs

Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.

University of Copenhagen

N1-Benzoyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity.

Cnrs

N2-benzyl-N1-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor.

Upr 2301 Centre National De La Recherche Scientifique

The discovery of novel calcium sensing receptor negative allosteric modulators.

Pfizer

Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists.

Bristol-Myers Squibb Pharmaceutical Research Institute

Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism.

Mitsubishi Tanabe Pharma

Identification of potent, nonabsorbable agonists of the calcium-sensing receptor for GI-specific administration.

Glaxosmithkline